Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Doug Poucher has over 39 years of experience in food and drug matters, including over 16 years with the Food and Drug Administration (FDA). He is recognized for his knowledge, application and interpretation of QSR regulations for medical devices and CGMP regulations for pharmaceutical and biologic products (sterile and non-sterile dosage forms and active pharmaceutical ingredients).

Mr. Poucher, a non-lawyer, has significant experience in FDA inspection preparedness and response, including in the areas of deviation management (manufacturing non-conformance and failure investigations, corrective and preventative actions); quality systems; data and application integrity investigations; change control systems; facilities and equipment validation and controls; and conducting mock pre-approval audits and verification audits. He has provided consulting services to numerous pharmaceutical, biologic and medical device manufacturers in the U.S., Canada, Mexico, Eastern and Western Europe, Japan, China and Australia. Mr. Poucher has significant experience preparing communications to FDA in response to FDA-483s and Warning Letters, along with corrective action plans and quality improvement plans.

Memberships and Affiliations

  • Parenteral Drug Association
  • Recipient of the Food and Drug Administration Commissioner’s Special Citation.